# Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia

> **NCT00218374** · NA · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 60 (actual)

## Conditions studied

- Hyperalgesia
- Opioid-Related Disorders

## Interventions

- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT00218374
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218374, "Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00218374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*